SOT 2020  | Anaheim, CA

March 15 - 19, 2020

NanoSurface - Booth 1345

Platform Presentation  |  Session: Bridging the Translational Gap in Drug Development

"Enhancing Stem Cell-Based Toxicity Assays by Engineering the Culture Niche in a High-Throughput Assay-Agnostic Manner"

• Date: Tuesday, March 17, 2020 

• Time: 08:15 AM - 08:30 AM PT

• Room: CC Room 204 A

• Presenter: Dr. Nicholas Geisse, Chief Science Officer, NanoSurface Biomedical

Exhibitor Presentation

“Biomimetic Cues to Enhance Functional Phenotypes in Cultured Stem Cells”

• Date: Tuesday, March 17, 2020 

• Time: 04:30 PM - 05:30 AM PT

• Room: 206B

• Presenter: Dr. Nicholas Geisse, Chief Science Officer, NanoSurface Biomedical

Session Description:

The predictivity of stem cell-based assays is correlated to the cells’ phenotypic maturity. However, cells in vitro lose these key phenotypes. NanoSurface Biomedical’s technologies provide extracellular cues that mimic a cell’s natural niche, which enhances their phenotypic maturity to improve assay results in an instrument- and assay-agnostic manner.

To learn more about the SOT meeting, please click here.

NanoSurface Biomedical will also be attending the Agilent Cardio Symposium taking place immediately prior to the SOT conference in Anaheim on March 15.